GlaxoSmithKline PLC (GSK)
33.74
+0.13 +0.39%
NYSE
Mar 1, 16:59
USD
View All Key Stats
Key Stats
| Income Statement | |
| Revenue (TTM) | 43.81B |
| Revenue (Quarterly YoY Growth) | Upgrade |
| EPS Diluted (TTM) | 2.908 |
| EPS Diluted (Quarterly YoY Growth) | Upgrade |
| Net Income (TTM) | 7.313B |
| Profitability | |
| Gross Profit Margin (Quarterly) | 63.71% |
| Profit Margin (Quarterly) | 7.75% |
| Dividend | |
| Dividend Yield (Forward) | Upgrade |
| Dividend Yield | 6.25% |
| Price and Valuation | |
| Market Cap | 84.87B |
| 52 Week High (Daily) | Upgrade |
| 52 Week Low (Daily) | Upgrade |
| PS Ratio | 1.936 |
| PE Ratio | 11.60 |
| Price to Book Value | 4.269 |
| Other | |
| Beta (5Y) | Upgrade |
| Debt to Equity Ratio | 1.861 |
| Free Cash Flow (Quarterly) | 3.835B |
| Return on Equity | Upgrade |
View All GSK News
News
-
WireHeadlineTime (ET)
-
Yahoo03/01 14:58
-
Yahoo03/01 13:45
-
Yahoo03/01 08:00
-
Yahoo02/26 18:55
-
Yahoo02/26 13:16
-
Yahoo02/26 10:06
-
Yahoo02/25 14:39
-
Yahoo02/25 14:13
-
SA Breaking News02/25 13:52
-
Yahoo02/25 11:26
-
Yahoo02/25 10:20
-
Yahoo02/25 07:30
-
Yahoo02/25 07:00
-
SA Breaking News02/24 13:12
-
Yahoo02/24 09:31
-
Yahoo02/22 17:23
-
Yahoo02/22 08:01
-
Yahoo02/22 07:14
-
SA Breaking News02/22 06:17
-
Yahoo02/22 06:10
View All Events
Events
| Date | Type | Description |
|---|---|---|
| 04/29/2021 | Earnings | GlaxoSmithKline PLC First Quarter Earnings Results for 2021 |
| 02/18/2021 | Dividends | Amount: 0.6280, Declared Date: Feb 03 2021, Pay Date: Apr 08 2021 |
| 02/03/2021 | Earnings | GlaxoSmithKline PLC Fourth Quarter Earnings Results for 2020 |
| 11/12/2020 | Dividends | Amount: 0.5167, Declared Date: Oct 28 2020, Pay Date: Jan 14 2021 |
| 10/28/2020 | Earnings | GlaxoSmithKline PLC Third Quarter Earnings Results for 2020 |
| 08/13/2020 | Dividends | Amount: 0.4929, Declared Date: Aug 12 2020, Pay Date: Oct 08 2020 |
| 07/29/2020 | Earnings | GlaxoSmithKline PLC Second Quarter Earnings Results for 2020 |
| 05/14/2020 | Dividends | Amount: 0.4720, Declared Date: Apr 29 2020, Pay Date: Jul 09 2020 |
| 05/06/2020 14:45 BST | Misc | GlaxoSmithKline PLC Annual General Meeting for 2019 |
| 04/29/2020 | Earnings | GlaxoSmithKline PLC First Quarter Earnings Results for 2020 |
Fundamentals
Income Statement View Statement
Ratings & Reports
- Y-Rating Upgrade
- Value Score Upgrade
- Fundamental Score Upgrade
- Valuation (Hist. Mult.) Upgrade
- Y-Rating Report Download
- One Page Report Download
Advertisement
Edit
Profile
- URL: http://www.gsk.com
- Investor Relations URL: http://www.gsk.com/en-gb/investors/
- HQ State/Province: N/A
- Sector: Healthcare
- Industry: Drug Manufacturers - General
- Equity Style: Large Cap/Blend
- Next Earnings Release: Apr. 29, 2021
- Last Earnings Release: Feb. 03, 2021
- Next Ex-Dividend Date: N/A
- Last Ex-Dividend Date: Feb. 18, 2021
- Description: In the pharmaceutical industry, GlaxoSmithKline ranks as one of the largest companies by total sales. The company wields its might across several therapeutic classes, including respiratory, oncology, and antiviral, as well as vaccines and consumer healthcare products. Glaxo uses joint ventures to gain additional scale in certain markets like HIV and consumer products.
Analyst Coverage
| Consensus Recommendations | |
| Buy Recommendations | Upgrade |
| Outperform Recommendations | Upgrade |
| Hold Recommendations | Upgrade |
| Underperform Recommendations | Upgrade |
| Sell Recommendations | Upgrade |
| Consensus Recommendation | Upgrade |
| Consensus Rating | Upgrade |
| Target Price | |
| Price | 33.74 |
| Price Target | Upgrade |
| Price Target Upside (Daily) | Upgrade |
Top Fund Holders
| Symbol | Name | Weighting |
|---|---|---|
| LIFE.TO | Evolve Global Healthcare Enh Yld ETF Hdg | 4.74% |
| CIG21506 | CI Black Creek Global Leaders Class I (USD) | 4.16% |
| PPH | VanEck Vectors Pharmaceutical ETF | 3.99% |
| VIRS | Pacer BioThreat Strategy ETF | 3.10% |
| DODGX | Dodge & Cox Stock | 2.16% |
| EUR.A.TO | FT AlphaDEX European Div ETF Adv | 2.15% |
| JTA | Nuveen Tax-Adv Total Return | 2.06% |
| DODBX | Dodge & Cox Balanced | 1.57% |
| RRIGX | T. Rowe Price International Value Eq R | 1.34% |
| FGIKX | Fidelity® Growth & Income K | 1.34% |
| FGLGX | Fidelity® Series Large Cap Stock | 1.27% |
Other Resources
- 13F Filings Whale Wisdom
- Call Transcripts Seeking Alpha
- Insider Trading Morningstar
- Institutional Ownership Nasdaq
- SEC Filings SEC
- GSK Tweets Stocktwits
Advertisement
